These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 14436950)

  • 1. [Study on the absence of antibacterial properties in a new synthetic antidiabetic, 1-(3-aminobenzenesulfonyl)-3-n-butylurea or SB 1].
    REGAMEY RH
    Schweiz Med Wochenschr; 1959 Nov; 89():1183-6. PubMed ID: 14436950
    [No Abstract]   [Full Text] [Related]  

  • 2. [First clinical trials of a new synthetic antidiabetic SB 1 or 1-(3-aminobenzenesulfonyl)-3-n-butylurea].
    BICKEL G; KORALNIK O
    Schweiz Med Wochenschr; 1959 Nov; 89():1186-91. PubMed ID: 13800475
    [No Abstract]   [Full Text] [Related]  

  • 3. [Findings in the course of antidiabetic treatment with 1-para-aminobenzenesulfonyl-3-N-butyl urea].
    MORSIANI M; SERRAVALLI S
    Arcisp S Anna Ferrara; 1956; 9(4):747-59. PubMed ID: 13382613
    [No Abstract]   [Full Text] [Related]  

  • 4. Hypoglycaemic activity of N-benzenesulphonyl-N'-iso-propylurea and N-benzenesulphonyl-N'-n-butylurea in experimental animals.
    TONSE U; ANANTHANARAYANAN KG; MHASALKAR MY; SHAH MH; DELIWALA CV
    Nature; 1962 Mar; 193():891. PubMed ID: 13921881
    [No Abstract]   [Full Text] [Related]  

  • 5. [Dependency of serum concentration and blood sugar effect of N-4-methylbenzene-sulfonyl-N-butylurea (rastinon, D 860, artosin) on dosage in prolonged intravenous infusions].
    HASSELBLATT A; BLUDAU W
    Klin Wochenschr; 1958 Feb; 36(4):157-63. PubMed ID: 13540141
    [No Abstract]   [Full Text] [Related]  

  • 6. [Tonographic studies on the effect of N-2-(p-aminobenzenesulfonyl)-N-2-butylurea on the aqueous humor balance in man].
    BOECK J; STEPANIK J; TERNES T
    Wien Klin Wochenschr; 1959 Dec; 71():952-3. PubMed ID: 13801952
    [No Abstract]   [Full Text] [Related]  

  • 7. [FATTY LIVER PATHOGENESIS IN CARASSIUS AURATUS IN GLUCOSE-RICH MEDIUM AND ITS ALTERATION BY N1-N-BUTYLBIGUANIDE AND N'-(4-METHYLBENZOYLSULFONYL)-N'-BUTYLUREA (TOLBUTAMIDE)].
    KOEHLER E; LIPPMANN HG
    Acta Biol Med Ger; 1963; 11():866-72. PubMed ID: 14121880
    [No Abstract]   [Full Text] [Related]  

  • 8. [Results of ambulatory treatment of diabetes mellitus with 1-p-aminobenzenesulfonyl 3n-butylurea].
    ANDREANI G
    Minerva Med; 1956 Oct; 47(87):1435-9. PubMed ID: 13387284
    [No Abstract]   [Full Text] [Related]  

  • 9. [The teratogenic action of a hypoglycemic sulfonylurea (N-sulfanilil-N-butylurea-BZ55)].
    De Meyer R; Isaac-Mathy M
    Ann Endocrinol (Paris); 1958; 19(1):167-72. PubMed ID: 13534005
    [No Abstract]   [Full Text] [Related]  

  • 10. [Experimental studies on the mechanism of the therapeutic effect of antidiabetic sulfonyl-urea].
    OHONO T
    Nihon Naibunpi Gakkai Zasshi; 1961 Nov; 37():869-95. PubMed ID: 14481417
    [No Abstract]   [Full Text] [Related]  

  • 11. [The therapy of diabetes mellitus with SB 1].
    BERINGER A
    Wien Med Wochenschr; 1960 Feb; 110():109-11. PubMed ID: 13799474
    [No Abstract]   [Full Text] [Related]  

  • 12. Correlation of plasma levels of oral antidiabetic agents with blood sugar responses.
    CREUTZFELDT W; ANDREU-KERN F; DISCHER R
    Ann N Y Acad Sci; 1959 Sep; 82():537-46. PubMed ID: 13812821
    [No Abstract]   [Full Text] [Related]  

  • 13. Antioxidant and Antidiabetic Effects of Flavonoids: A Structure-Activity Relationship Based Study.
    Sarian MN; Ahmed QU; Mat So'ad SZ; Alhassan AM; Murugesu S; Perumal V; Syed Mohamad SNA; Khatib A; Latip J
    Biomed Res Int; 2017; 2017():8386065. PubMed ID: 29318154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antidiabetic effect of total flavonoids from Sanguis draxonis in type 2 diabetic rats.
    Chen F; Xiong H; Wang J; Ding X; Shu G; Mei Z
    J Ethnopharmacol; 2013 Oct; 149(3):729-36. PubMed ID: 23933499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacological research on a new hypoglycemic agent: 1-(p-chlorobenzensulfonyl)-3-propyl-urea].
    BRUNORI F; DELL'OMODARME G
    Gazz Med Ital; 1960 May; 119():279-88. PubMed ID: 13848137
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of HB 419--a new oral antidiabetic--on fat metabolism].
    Stork H; Schmidt FH; Bänder A; Pfaff W
    Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1373-8. PubMed ID: 5394456
    [No Abstract]   [Full Text] [Related]  

  • 17. [Action on the blood sugar level of some new N,N'-bisubstituted urea derivatives].
    SANSONE M; MARINARI UM; DELL'OMODARME G
    Gazz Med Ital; 1961 Oct; 120():384-6. PubMed ID: 14497010
    [No Abstract]   [Full Text] [Related]  

  • 18. Isolated flavonoids from Ficus racemosa stem bark possess antidiabetic, hypolipidemic and protective effects in albino Wistar rats.
    Keshari AK; Kumar G; Kushwaha PS; Bhardwaj M; Kumar P; Rawat A; Kumar D; Prakash A; Ghosh B; Saha S
    J Ethnopharmacol; 2016 Apr; 181():252-62. PubMed ID: 26869543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mechanism of action of the hypoglycemic urea derivative N-(4-methyl-benzosulfonyl)-N'-butyl urea].
    KNITSCH KW
    Hoppe Seylers Z Physiol Chem; 1957; 309(4-6):184-9. PubMed ID: 13513009
    [No Abstract]   [Full Text] [Related]  

  • 20. [Our experience with the therapeutic use of a new sulfanylurea: N-propyl-N-(p-chlorobenzensulfonyl) urea-P607-by oral route in diabetes mellitus].
    SIGNORELLI S; POLOSA P
    Minerva Med; 1959 Aug; 50():2535-42. PubMed ID: 14446587
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.